SCHEMBL25120657

SCHEMBL25120657

Cc1ccccc1-c1ccnc(Cl)c1C=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ LRRK2 Q5S007 1/20 0.38
▸ CYP1A2 P05177 3/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ KDM5A P29375 1/20 0.37
▸ KDM4C Q9H3R0 1/20 0.37
▸ KDM5B Q9UGL1 1/20 0.37
▸ PLA2G7 Q13093 2/20 0.36
▸ GPBAR1 Q8TDU6 5/20 0.36
▸ LMNA P02545 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25120516 0.83 ALDH1A1 (0.45) TP53LRRK2ALDH1A1MEN1KMT2A
SCHEMBL25120559 0.80 GPBAR1 (0.44) KDM4EALDH1A1GPBAR1MEN1KMT2A
SCHEMBL30949157 0.80 GPBAR1 (0.44) KDM4EALDH1A1GPBAR1MEN1KMT2A
SCHEMBL8550487 0.77 MEN1 (0.39) MAPTKDM4ENPSR1LRRK2CYP1A2
SCHEMBL14620918 0.76 KDM4E (0.39) MAPTKDM4ERECQLNPSR1CYP1A2
SCHEMBL1830917 0.76 ALDH1A1 (0.46) KDM4ENPSR1CYP1A2CYP2C19ALDH1A1
SCHEMBL12241357 0.76 LRRK2 (0.39) MAPTTP53LRRK2CYP1A2CYP3A4
SCHEMBL30377825 0.75 KDM5A (0.48) MAPTTP53ALDH1A1KDM5AKDM4C
SCHEMBL5526122 0.75 KDM5A (0.48) MAPTTP53ALDH1A1KDM5AKDM4C
SCHEMBL30377092 0.74 HSD17B10 (0.43) MAPTTP53CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230144095-A1 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS X-CHEM GLOBAL HQ 2023-05-11 — — US disclosed
US-20230144095-A1 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS X-CHEM GLOBAL HQ 2023-05-11 — — US disclosed
WO-2023049364-A1 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2023-03-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230144095-A1 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS SCN1A, SCN1B, CACNA1A MAPT 231/4885KDM4E 1263/4885RECQL 1550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback